Prognostic influence of 5 alpha reductase inhibitors in patients with localized prostate cancer under active surveillance

Ozkan T. A., Cebeci O. O., Cevik I., DİLLİOĞLUGİL Ö.

TURKISH JOURNAL OF UROLOGY, cilt.44, sa.2, ss.132-137, 2018 (ESCI) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 44 Sayı: 2
  • Basım Tarihi: 2018
  • Doi Numarası: 10.5152/tud.2017.39660
  • Dergi Adı: TURKISH JOURNAL OF UROLOGY
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.132-137
  • Anahtar Kelimeler: 5-alpha-reductase inhibitors, active surveillance, prostate cancer, DUTASTERIDE, PROGRESSION, GUIDELINES, DIAGNOSIS, BIOPSY, RISK, MEN
  • Kocaeli Üniversitesi Adresli: Evet

Özet

Objective: The incidence of prostate adenocarcinoma (PCa) is increased with the use of prostate-specific antigen (PSA). In the current study, we aimed to investigate the impact of 5-alpha-reductase inhibitors (5-ARI) on pathological progression in patients followed by active surveillance (AS).